使用阴性对照结果比较心肌梗死后 PCSK9 单克隆抗体治疗策略：目标试验模拟研究

IF 4.7 2区医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

Epidemiology Pub Date : 2024-03-12 DOI:10.1097/ede.0000000000001730

Rosa Sloot, Alexander Breskin, Lisandro D Colantonio, Andrew G Allmon, Ying Yu, Swati Sakhuja, Ligong Chen, Paul Muntner, M Alan Brookhart, Nafeesa Dhalwani

{"title":"使用阴性对照结果比较心肌梗死后 PCSK9 单克隆抗体治疗策略：目标试验模拟研究","authors":"Rosa Sloot, Alexander Breskin, Lisandro D Colantonio, Andrew G Allmon, Ying Yu, Swati Sakhuja, Ligong Chen, Paul Muntner, M Alan Brookhart, Nafeesa Dhalwani","doi":"10.1097/ede.0000000000001730","DOIUrl":null,"url":null,"abstract":"Initiation of proprotein convertase subtilisin/kexin type 9 monoclonal antibody (PCSK9 mAb) for lipid-lowering following myocardial infarction (MI) is likely affected by patients' prognostic factors, potentially leading to bias when comparing real-world treatment effects.","PeriodicalId":11779,"journal":{"name":"Epidemiology","volume":null,"pages":null},"PeriodicalIF":4.7000,"publicationDate":"2024-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Comparing PCSK9 Monoclonal Antibody Treatment Strategies Following Myocardial Infarction Using Negative Control Outcomes: A Target Trial Emulation Study.\",\"authors\":\"Rosa Sloot, Alexander Breskin, Lisandro D Colantonio, Andrew G Allmon, Ying Yu, Swati Sakhuja, Ligong Chen, Paul Muntner, M Alan Brookhart, Nafeesa Dhalwani\",\"doi\":\"10.1097/ede.0000000000001730\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Initiation of proprotein convertase subtilisin/kexin type 9 monoclonal antibody (PCSK9 mAb) for lipid-lowering following myocardial infarction (MI) is likely affected by patients' prognostic factors, potentially leading to bias when comparing real-world treatment effects.\",\"PeriodicalId\":11779,\"journal\":{\"name\":\"Epidemiology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.7000,\"publicationDate\":\"2024-03-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Epidemiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1097/ede.0000000000001730\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Epidemiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/ede.0000000000001730","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}

引用次数: 0

摘要

心肌梗死（MI）后开始使用9型亚铁基转移酶/kexin单克隆抗体（PCSK9 mAb）降脂可能会受到患者预后因素的影响，从而可能导致在比较实际治疗效果时出现偏差。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Comparing PCSK9 Monoclonal Antibody Treatment Strategies Following Myocardial Infarction Using Negative Control Outcomes: A Target Trial Emulation Study.

Initiation of proprotein convertase subtilisin/kexin type 9 monoclonal antibody (PCSK9 mAb) for lipid-lowering following myocardial infarction (MI) is likely affected by patients' prognostic factors, potentially leading to bias when comparing real-world treatment effects.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Epidemiology 医学-公共卫生、环境卫生与职业卫生

CiteScore

6.70

自引率

3.70%

发文量

177

审稿时长

6-12 weeks

期刊介绍： Epidemiology publishes original research from all fields of epidemiology. The journal also welcomes review articles and meta-analyses, novel hypotheses, descriptions and applications of new methods, and discussions of research theory or public health policy. We give special consideration to papers from developing countries.